Global Personalized Cell Therapeutic Supply, Demand and Key Producers, 2023-2029
Page: 119
Published Date: 17 Feb 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Related Reports
- Product Tags
Description
The global Personalized Cell Therapeutic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem cells. Specialized treatment of numerous chronic diseases such as autoimmune and cancer through vaccinating living cells into the body of patients to boost the personalized cell therapy market. As there are multiple types of living cells such as immature and mature living cell, blood and bone marrow cell and embryonic stem cells that are mainly utilized in personalized cell therapy.
This report studies the global Personalized Cell Therapeutic production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Personalized Cell Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Personalized Cell Therapeutic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Personalized Cell Therapeutic total production and demand, 2018-2029, (K Units)
Global Personalized Cell Therapeutic total production value, 2018-2029, (USD Million)
Global Personalized Cell Therapeutic production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Personalized Cell Therapeutic consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Personalized Cell Therapeutic domestic production, consumption, key domestic manufacturers and share
Global Personalized Cell Therapeutic production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Personalized Cell Therapeutic production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Personalized Cell Therapeutic production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Personalized Cell Therapeutic market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc, Bausch Health Companies Inc, Teva Pharmaceutical Industries Ltd, Cipla, Lupin, Sun Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, AstraZeneca and GSK Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Personalized Cell Therapeutic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Personalized Cell Therapeutic Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Personalized Cell Therapeutic Market, Segmentation by Type
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other
Global Personalized Cell Therapeutic Market, Segmentation by Application
Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other
Companies Profiled:
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Key Questions Answered
1. How big is the global Personalized Cell Therapeutic market?
2. What is the demand of the global Personalized Cell Therapeutic market?
3. What is the year over year growth of the global Personalized Cell Therapeutic market?
4. What is the production and production value of the global Personalized Cell Therapeutic market?
5. Who are the key producers in the global Personalized Cell Therapeutic market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Personalized Cell Therapeutic Introduction
1.2 World Personalized Cell Therapeutic Supply & Forecast
1.2.1 World Personalized Cell Therapeutic Production Value (2018 & 2022 & 2029)
1.2.2 World Personalized Cell Therapeutic Production (2018-2029)
1.2.3 World Personalized Cell Therapeutic Pricing Trends (2018-2029)
1.3 World Personalized Cell Therapeutic Production by Region (Based on Production Site)
1.3.1 World Personalized Cell Therapeutic Production Value by Region (2018-2029)
1.3.2 World Personalized Cell Therapeutic Production by Region (2018-2029)
1.3.3 World Personalized Cell Therapeutic Average Price by Region (2018-2029)
1.3.4 North America Personalized Cell Therapeutic Production (2018-2029)
1.3.5 Europe Personalized Cell Therapeutic Production (2018-2029)
1.3.6 China Personalized Cell Therapeutic Production (2018-2029)
1.3.7 Japan Personalized Cell Therapeutic Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Personalized Cell Therapeutic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Personalized Cell Therapeutic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World Personalized Cell Therapeutic Demand (2018-2029)
2.2 World Personalized Cell Therapeutic Consumption by Region
2.2.1 World Personalized Cell Therapeutic Consumption by Region (2018-2023)
2.2.2 World Personalized Cell Therapeutic Consumption Forecast by Region (2024-2029)
2.3 United States Personalized Cell Therapeutic Consumption (2018-2029)
2.4 China Personalized Cell Therapeutic Consumption (2018-2029)
2.5 Europe Personalized Cell Therapeutic Consumption (2018-2029)
2.6 Japan Personalized Cell Therapeutic Consumption (2018-2029)
2.7 South Korea Personalized Cell Therapeutic Consumption (2018-2029)
2.8 ASEAN Personalized Cell Therapeutic Consumption (2018-2029)
2.9 India Personalized Cell Therapeutic Consumption (2018-2029)
3 World Personalized Cell Therapeutic Manufacturers Competitive Analysis
3.1 World Personalized Cell Therapeutic Production Value by Manufacturer (2018-2023)
3.2 World Personalized Cell Therapeutic Production by Manufacturer (2018-2023)
3.3 World Personalized Cell Therapeutic Average Price by Manufacturer (2018-2023)
3.4 Personalized Cell Therapeutic Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Personalized Cell Therapeutic Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Personalized Cell Therapeutic in 2022
3.5.3 Global Concentration Ratios (CR8) for Personalized Cell Therapeutic in 2022
3.6 Personalized Cell Therapeutic Market: Overall Company Footprint Analysis
3.6.1 Personalized Cell Therapeutic Market: Region Footprint
3.6.2 Personalized Cell Therapeutic Market: Company Product Type Footprint
3.6.3 Personalized Cell Therapeutic Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Personalized Cell Therapeutic Production Value Comparison
4.1.1 United States VS China: Personalized Cell Therapeutic Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Personalized Cell Therapeutic Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Personalized Cell Therapeutic Production Comparison
4.2.1 United States VS China: Personalized Cell Therapeutic Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Personalized Cell Therapeutic Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Personalized Cell Therapeutic Consumption Comparison
4.3.1 United States VS China: Personalized Cell Therapeutic Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Personalized Cell Therapeutic Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Personalized Cell Therapeutic Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Personalized Cell Therapeutic Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Personalized Cell Therapeutic Production Value (2018-2023)
4.4.3 United States Based Manufacturers Personalized Cell Therapeutic Production (2018-2023)
4.5 China Based Personalized Cell Therapeutic Manufacturers and Market Share
4.5.1 China Based Personalized Cell Therapeutic Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Personalized Cell Therapeutic Production Value (2018-2023)
4.5.3 China Based Manufacturers Personalized Cell Therapeutic Production (2018-2023)
4.6 Rest of World Based Personalized Cell Therapeutic Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Personalized Cell Therapeutic Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Personalized Cell Therapeutic Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Personalized Cell Therapeutic Production (2018-2023)
5 Market Analysis by Type
5.1 World Personalized Cell Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Embryonic Stem Cells
5.2.2 Adult Stem Cell
5.2.3 Induced Pluripotent Cells
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Personalized Cell Therapeutic Production by Type (2018-2029)
5.3.2 World Personalized Cell Therapeutic Production Value by Type (2018-2029)
5.3.3 World Personalized Cell Therapeutic Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Personalized Cell Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cardiovascular Diseases
6.2.2 Neurological Disorders
6.2.3 Diabetes
6.2.4 Oncology
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Personalized Cell Therapeutic Production by Application (2018-2029)
6.3.2 World Personalized Cell Therapeutic Production Value by Application (2018-2029)
6.3.3 World Personalized Cell Therapeutic Average Price by Application (2018-2029)
7 Company Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Details
7.1.2 AbbVie Inc Major Business
7.1.3 AbbVie Inc Personalized Cell Therapeutic Product and Services
7.1.4 AbbVie Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Inc Recent Developments/Updates
7.1.6 AbbVie Inc Competitive Strengths & Weaknesses
7.2 Bausch Health Companies Inc
7.2.1 Bausch Health Companies Inc Details
7.2.2 Bausch Health Companies Inc Major Business
7.2.3 Bausch Health Companies Inc Personalized Cell Therapeutic Product and Services
7.2.4 Bausch Health Companies Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bausch Health Companies Inc Recent Developments/Updates
7.2.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Cipla
7.4.1 Cipla Details
7.4.2 Cipla Major Business
7.4.3 Cipla Personalized Cell Therapeutic Product and Services
7.4.4 Cipla Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Cipla Recent Developments/Updates
7.4.6 Cipla Competitive Strengths & Weaknesses
7.5 Lupin
7.5.1 Lupin Details
7.5.2 Lupin Major Business
7.5.3 Lupin Personalized Cell Therapeutic Product and Services
7.5.4 Lupin Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lupin Recent Developments/Updates
7.5.6 Lupin Competitive Strengths & Weaknesses
7.6 Sun Pharmaceuticals Industries Ltd
7.6.1 Sun Pharmaceuticals Industries Ltd Details
7.6.2 Sun Pharmaceuticals Industries Ltd Major Business
7.6.3 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product and Services
7.6.4 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
7.6.6 Sun Pharmaceuticals Industries Ltd Competitive Strengths & Weaknesses
7.7 Hikma Pharmaceuticals PLC
7.7.1 Hikma Pharmaceuticals PLC Details
7.7.2 Hikma Pharmaceuticals PLC Major Business
7.7.3 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product and Services
7.7.4 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
7.7.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Personalized Cell Therapeutic Product and Services
7.8.4 AstraZeneca Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 GSK Plc
7.9.1 GSK Plc Details
7.9.2 GSK Plc Major Business
7.9.3 GSK Plc Personalized Cell Therapeutic Product and Services
7.9.4 GSK Plc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Plc Recent Developments/Updates
7.9.6 GSK Plc Competitive Strengths & Weaknesses
7.10 Pfizer Inc
7.10.1 Pfizer Inc Details
7.10.2 Pfizer Inc Major Business
7.10.3 Pfizer Inc Personalized Cell Therapeutic Product and Services
7.10.4 Pfizer Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer Inc Recent Developments/Updates
7.10.6 Pfizer Inc Competitive Strengths & Weaknesses
7.11 Amneal Pharmaceuticals LLC
7.11.1 Amneal Pharmaceuticals LLC Details
7.11.2 Amneal Pharmaceuticals LLC Major Business
7.11.3 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product and Services
7.11.4 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
7.11.6 Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.12 Alvogen
7.12.1 Alvogen Details
7.12.2 Alvogen Major Business
7.12.3 Alvogen Personalized Cell Therapeutic Product and Services
7.12.4 Alvogen Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Alvogen Recent Developments/Updates
7.12.6 Alvogen Competitive Strengths & Weaknesses
7.13 F. Hoffmann-La Roche Ltd
7.13.1 F. Hoffmann-La Roche Ltd Details
7.13.2 F. Hoffmann-La Roche Ltd Major Business
7.13.3 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product and Services
7.13.4 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.13.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.14 Amgen Inc
7.14.1 Amgen Inc Details
7.14.2 Amgen Inc Major Business
7.14.3 Amgen Inc Personalized Cell Therapeutic Product and Services
7.14.4 Amgen Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Amgen Inc Recent Developments/Updates
7.14.6 Amgen Inc Competitive Strengths & Weaknesses
7.15 Jazz Pharmaceuticals, Inc
7.15.1 Jazz Pharmaceuticals, Inc Details
7.15.2 Jazz Pharmaceuticals, Inc Major Business
7.15.3 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
7.15.4 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Jazz Pharmaceuticals, Inc Recent Developments/Updates
7.15.6 Jazz Pharmaceuticals, Inc Competitive Strengths & Weaknesses
7.16 Amicus Therapeutics, Inc
7.16.1 Amicus Therapeutics, Inc Details
7.16.2 Amicus Therapeutics, Inc Major Business
7.16.3 Amicus Therapeutics, Inc Personalized Cell Therapeutic Product and Services
7.16.4 Amicus Therapeutics, Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Amicus Therapeutics, Inc Recent Developments/Updates
7.16.6 Amicus Therapeutics, Inc Competitive Strengths & Weaknesses
7.17 MeiraGTx Limited
7.17.1 MeiraGTx Limited Details
7.17.2 MeiraGTx Limited Major Business
7.17.3 MeiraGTx Limited Personalized Cell Therapeutic Product and Services
7.17.4 MeiraGTx Limited Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 MeiraGTx Limited Recent Developments/Updates
7.17.6 MeiraGTx Limited Competitive Strengths & Weaknesses
7.18 Rocket Pharmaceuticals, Inc
7.18.1 Rocket Pharmaceuticals, Inc Details
7.18.2 Rocket Pharmaceuticals, Inc Major Business
7.18.3 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
7.18.4 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Rocket Pharmaceuticals, Inc Recent Developments/Updates
7.18.6 Rocket Pharmaceuticals, Inc Competitive Strengths & Weaknesses
7.19 Gilead Sciences, Inc
7.19.1 Gilead Sciences, Inc Details
7.19.2 Gilead Sciences, Inc Major Business
7.19.3 Gilead Sciences, Inc Personalized Cell Therapeutic Product and Services
7.19.4 Gilead Sciences, Inc Personalized Cell Therapeutic Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Gilead Sciences, Inc Recent Developments/Updates
7.19.6 Gilead Sciences, Inc Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Personalized Cell Therapeutic Industry Chain
8.2 Personalized Cell Therapeutic Upstream Analysis
8.2.1 Personalized Cell Therapeutic Core Raw Materials
8.2.2 Main Manufacturers of Personalized Cell Therapeutic Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Personalized Cell Therapeutic Production Mode
8.6 Personalized Cell Therapeutic Procurement Model
8.7 Personalized Cell Therapeutic Industry Sales Model and Sales Channels
8.7.1 Personalized Cell Therapeutic Sales Model
8.7.2 Personalized Cell Therapeutic Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Personalized Cell Therapeutic Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Personalized Cell Therapeutic Production Value by Region (2018-2023) & (USD Million)
Table 3. World Personalized Cell Therapeutic Production Value by Region (2024-2029) & (USD Million)
Table 4. World Personalized Cell Therapeutic Production Value Market Share by Region (2018-2023)
Table 5. World Personalized Cell Therapeutic Production Value Market Share by Region (2024-2029)
Table 6. World Personalized Cell Therapeutic Production by Region (2018-2023) & (K Units)
Table 7. World Personalized Cell Therapeutic Production by Region (2024-2029) & (K Units)
Table 8. World Personalized Cell Therapeutic Production Market Share by Region (2018-2023)
Table 9. World Personalized Cell Therapeutic Production Market Share by Region (2024-2029)
Table 10. World Personalized Cell Therapeutic Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Personalized Cell Therapeutic Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Personalized Cell Therapeutic Major Market Trends
Table 13. World Personalized Cell Therapeutic Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Personalized Cell Therapeutic Consumption by Region (2018-2023) & (K Units)
Table 15. World Personalized Cell Therapeutic Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Personalized Cell Therapeutic Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Personalized Cell Therapeutic Producers in 2022
Table 18. World Personalized Cell Therapeutic Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Personalized Cell Therapeutic Producers in 2022
Table 20. World Personalized Cell Therapeutic Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Personalized Cell Therapeutic Company Evaluation Quadrant
Table 22. World Personalized Cell Therapeutic Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Personalized Cell Therapeutic Production Site of Key Manufacturer
Table 24. Personalized Cell Therapeutic Market: Company Product Type Footprint
Table 25. Personalized Cell Therapeutic Market: Company Product Application Footprint
Table 26. Personalized Cell Therapeutic Competitive Factors
Table 27. Personalized Cell Therapeutic New Entrant and Capacity Expansion Plans
Table 28. Personalized Cell Therapeutic Mergers & Acquisitions Activity
Table 29. United States VS China Personalized Cell Therapeutic Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Personalized Cell Therapeutic Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Personalized Cell Therapeutic Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Personalized Cell Therapeutic Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Personalized Cell Therapeutic Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Personalized Cell Therapeutic Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Personalized Cell Therapeutic Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Personalized Cell Therapeutic Production Market Share (2018-2023)
Table 37. China Based Personalized Cell Therapeutic Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Personalized Cell Therapeutic Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Personalized Cell Therapeutic Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Personalized Cell Therapeutic Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Personalized Cell Therapeutic Production Market Share (2018-2023)
Table 42. Rest of World Based Personalized Cell Therapeutic Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Personalized Cell Therapeutic Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Personalized Cell Therapeutic Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Personalized Cell Therapeutic Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Personalized Cell Therapeutic Production Market Share (2018-2023)
Table 47. World Personalized Cell Therapeutic Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Personalized Cell Therapeutic Production by Type (2018-2023) & (K Units)
Table 49. World Personalized Cell Therapeutic Production by Type (2024-2029) & (K Units)
Table 50. World Personalized Cell Therapeutic Production Value by Type (2018-2023) & (USD Million)
Table 51. World Personalized Cell Therapeutic Production Value by Type (2024-2029) & (USD Million)
Table 52. World Personalized Cell Therapeutic Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Personalized Cell Therapeutic Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Personalized Cell Therapeutic Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Personalized Cell Therapeutic Production by Application (2018-2023) & (K Units)
Table 56. World Personalized Cell Therapeutic Production by Application (2024-2029) & (K Units)
Table 57. World Personalized Cell Therapeutic Production Value by Application (2018-2023) & (USD Million)
Table 58. World Personalized Cell Therapeutic Production Value by Application (2024-2029) & (USD Million)
Table 59. World Personalized Cell Therapeutic Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Personalized Cell Therapeutic Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Inc Major Business
Table 63. AbbVie Inc Personalized Cell Therapeutic Product and Services
Table 64. AbbVie Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AbbVie Inc Recent Developments/Updates
Table 66. AbbVie Inc Competitive Strengths & Weaknesses
Table 67. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 68. Bausch Health Companies Inc Major Business
Table 69. Bausch Health Companies Inc Personalized Cell Therapeutic Product and Services
Table 70. Bausch Health Companies Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bausch Health Companies Inc Recent Developments/Updates
Table 72. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product and Services
Table 76. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Cipla Basic Information, Manufacturing Base and Competitors
Table 80. Cipla Major Business
Table 81. Cipla Personalized Cell Therapeutic Product and Services
Table 82. Cipla Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Cipla Recent Developments/Updates
Table 84. Cipla Competitive Strengths & Weaknesses
Table 85. Lupin Basic Information, Manufacturing Base and Competitors
Table 86. Lupin Major Business
Table 87. Lupin Personalized Cell Therapeutic Product and Services
Table 88. Lupin Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lupin Recent Developments/Updates
Table 90. Lupin Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceuticals Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceuticals Industries Ltd Major Business
Table 93. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product and Services
Table 94. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
Table 96. Sun Pharmaceuticals Industries Ltd Competitive Strengths & Weaknesses
Table 97. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 98. Hikma Pharmaceuticals PLC Major Business
Table 99. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product and Services
Table 100. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 102. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Personalized Cell Therapeutic Product and Services
Table 106. AstraZeneca Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 110. GSK Plc Major Business
Table 111. GSK Plc Personalized Cell Therapeutic Product and Services
Table 112. GSK Plc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GSK Plc Recent Developments/Updates
Table 114. GSK Plc Competitive Strengths & Weaknesses
Table 115. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer Inc Major Business
Table 117. Pfizer Inc Personalized Cell Therapeutic Product and Services
Table 118. Pfizer Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Pfizer Inc Recent Developments/Updates
Table 120. Pfizer Inc Competitive Strengths & Weaknesses
Table 121. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 122. Amneal Pharmaceuticals LLC Major Business
Table 123. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product and Services
Table 124. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 126. Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 127. Alvogen Basic Information, Manufacturing Base and Competitors
Table 128. Alvogen Major Business
Table 129. Alvogen Personalized Cell Therapeutic Product and Services
Table 130. Alvogen Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Alvogen Recent Developments/Updates
Table 132. Alvogen Competitive Strengths & Weaknesses
Table 133. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 134. F. Hoffmann-La Roche Ltd Major Business
Table 135. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product and Services
Table 136. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 138. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 139. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 140. Amgen Inc Major Business
Table 141. Amgen Inc Personalized Cell Therapeutic Product and Services
Table 142. Amgen Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Amgen Inc Recent Developments/Updates
Table 144. Amgen Inc Competitive Strengths & Weaknesses
Table 145. Jazz Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 146. Jazz Pharmaceuticals, Inc Major Business
Table 147. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
Table 148. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Jazz Pharmaceuticals, Inc Recent Developments/Updates
Table 150. Jazz Pharmaceuticals, Inc Competitive Strengths & Weaknesses
Table 151. Amicus Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 152. Amicus Therapeutics, Inc Major Business
Table 153. Amicus Therapeutics, Inc Personalized Cell Therapeutic Product and Services
Table 154. Amicus Therapeutics, Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Amicus Therapeutics, Inc Recent Developments/Updates
Table 156. Amicus Therapeutics, Inc Competitive Strengths & Weaknesses
Table 157. MeiraGTx Limited Basic Information, Manufacturing Base and Competitors
Table 158. MeiraGTx Limited Major Business
Table 159. MeiraGTx Limited Personalized Cell Therapeutic Product and Services
Table 160. MeiraGTx Limited Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. MeiraGTx Limited Recent Developments/Updates
Table 162. MeiraGTx Limited Competitive Strengths & Weaknesses
Table 163. Rocket Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 164. Rocket Pharmaceuticals, Inc Major Business
Table 165. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product and Services
Table 166. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Rocket Pharmaceuticals, Inc Recent Developments/Updates
Table 168. Gilead Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 169. Gilead Sciences, Inc Major Business
Table 170. Gilead Sciences, Inc Personalized Cell Therapeutic Product and Services
Table 171. Gilead Sciences, Inc Personalized Cell Therapeutic Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Personalized Cell Therapeutic Upstream (Raw Materials)
Table 173. Personalized Cell Therapeutic Typical Customers
Table 174. Personalized Cell Therapeutic Typical Distributors
List of Figure
Figure 1. Personalized Cell Therapeutic Picture
Figure 2. World Personalized Cell Therapeutic Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Personalized Cell Therapeutic Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Personalized Cell Therapeutic Production (2018-2029) & (K Units)
Figure 5. World Personalized Cell Therapeutic Average Price (2018-2029) & (US$/Unit)
Figure 6. World Personalized Cell Therapeutic Production Value Market Share by Region (2018-2029)
Figure 7. World Personalized Cell Therapeutic Production Market Share by Region (2018-2029)
Figure 8. North America Personalized Cell Therapeutic Production (2018-2029) & (K Units)
Figure 9. Europe Personalized Cell Therapeutic Production (2018-2029) & (K Units)
Figure 10. China Personalized Cell Therapeutic Production (2018-2029) & (K Units)
Figure 11. Japan Personalized Cell Therapeutic Production (2018-2029) & (K Units)
Figure 12. Personalized Cell Therapeutic Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 15. World Personalized Cell Therapeutic Consumption Market Share by Region (2018-2029)
Figure 16. United States Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 17. China Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 18. Europe Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 19. Japan Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 20. South Korea Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 22. India Personalized Cell Therapeutic Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Personalized Cell Therapeutic by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Personalized Cell Therapeutic Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Personalized Cell Therapeutic Markets in 2022
Figure 26. United States VS China: Personalized Cell Therapeutic Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Personalized Cell Therapeutic Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Personalized Cell Therapeutic Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Personalized Cell Therapeutic Production Market Share 2022
Figure 30. China Based Manufacturers Personalized Cell Therapeutic Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Personalized Cell Therapeutic Production Market Share 2022
Figure 32. World Personalized Cell Therapeutic Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Personalized Cell Therapeutic Production Value Market Share by Type in 2022
Figure 34. Embryonic Stem Cells
Figure 35. Adult Stem Cell
Figure 36. Induced Pluripotent Cells
Figure 37. Other
Figure 38. World Personalized Cell Therapeutic Production Market Share by Type (2018-2029)
Figure 39. World Personalized Cell Therapeutic Production Value Market Share by Type (2018-2029)
Figure 40. World Personalized Cell Therapeutic Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Personalized Cell Therapeutic Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Personalized Cell Therapeutic Production Value Market Share by Application in 2022
Figure 43. Cardiovascular Diseases
Figure 44. Neurological Disorders
Figure 45. Diabetes
Figure 46. Oncology
Figure 47. Other
Figure 48. World Personalized Cell Therapeutic Production Market Share by Application (2018-2029)
Figure 49. World Personalized Cell Therapeutic Production Value Market Share by Application (2018-2029)
Figure 50. World Personalized Cell Therapeutic Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Personalized Cell Therapeutic Industry Chain
Figure 52. Personalized Cell Therapeutic Procurement Model
Figure 53. Personalized Cell Therapeutic Sales Model
Figure 54. Personalized Cell Therapeutic Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>